Effects of peptide nucleic acids (PNAs) on gene transcription

Minerva Biotecnologica

Volumn 11, Issue 3, 1999, Pages 205-210

  Mischiati, Carlo ^a   Rutigliano, Cristina ^a   Feriotto, Giordana ^a   Borgatti, Monica ^a   Bianchi, Nicoletta ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Gel retardation; Gene transcription; HIV 1; NF B; PNA

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEPTIDE NUCLEIC ACID; RNA; TRANSCRIPTION FACTOR;

BINDING SITE; DNA PROTEIN COMPLEX; GENE TARGETING; HUMAN IMMUNODEFICIENCY VIRUS 1; REVIEW; TRANSCRIPTION REGULATION;

EID: 0033388633     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Nielsen PE, Egholm M, Berg RH, Buchardt O. Sequence selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 1991;254:1497-500.
2. Egholm M, Buchardt O, Nielsen PE, Berg RH. Peptide nucleic acids (PNA). Oligonucleotide analogues with an achiral peptide backbone. J Am Chem Soc 1992;114:1895-7.
3. Buchardt O, Egholm M, Berg R, Nielsen PE. Peptide Nucleic Acids (PNA) and their potential applications in medicine and biotechnology. Trends Biotechnol 1993;11:384-6.
4. Hyrup B, Nielsen PE. Peptide Nucleic Acids (PNA). Synthesis, Properties and Potential Applications. Bioorg Biomed Chem 1996;4:5-23.
5. Good L, Nielsen PE. Progress in developing PNA as gene targeted drugs. Antisense Nucl Acid Drug Dev 1997;7:431-7.
6. Nielsen PE. Peptide nucleic acids as therapeutic agents. Curr Opin Struct Biol 1999;9:353-7.
7. Hanvey JC, Peffer NJ, Bisi JE, Thomson SA, Cadilla R, Josey JA et al. Antisense and antigene properties of peptide nucleic acids. Science 1992;258:1481-5.
8. Nielsen PE, Egholm M. Peptide Nucleic Acids: Protocols and Applications. Norfolk (England): Horizon Scientific Press, 1999.
9. Nielsen PE, Egholm M, Berg RH, Buchardt O. Peptide Nucleic Acids (PNA). Potential antisense and anti-gene agents. Anticancer Drug Des 1993;8:53-63.
10. Knudsen H, Nielsen PE. Antisense properties of duplex and triplex forming PNA. Nucleic Acids Res 1996;24:494-500.
11. Good L, Nielsen PE. Inhibition of translation and bacterial growth by peptide nucleic acids (PNA) targeted to ribosomal RNA. Proc Natl Acad Sci USA 1998;95:2073-6.
12. Good L, Nielsen PE. Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nature Biotechnol 1998;16: 355-8.
13. Mologni L, le Coutre P, Nielsen PE, Gambacorti-Passerini C. Additive antisense effects of different PNAs on the in vitro translation of the PML/RARα gene. Nucleic Acids Res 1998;26:1934-8.
14. Nielsen PE, Egholm M, Buchardt O. Sequence specific transcription arrest by PNA bound to the template strand. Gene 1994;149:139-45.
15. Dueholm K, Egholm M, Buchardt O. An efficient synthesis of Boc-aminoacetaldehyde and its application to the synthesis of N-(2-Boc-Aminoethyl)glycine, Esters Org Prepreparat and Proced Int 1993;25:457-61.
16. Larsen HJ, Nielsen PE. Transcription-mediated binding of peptide nucleic acid (PNA) to double stranded DNA: Sequence specific suicide transcription. Nucleic Acids Res 1996;24:458-63.
17. Praseuth D, Grigoriev M, Guieyssc AL, Pritchard LL, Harel-Bellan A, Nielsen PE et al. Peptide nucleic acids directed to the promoter of the α-chain of the interleukin-2 receptor. Biochim Biophys Acta 1996;1309:226-38.
18. Wang G, Xu X, Pace B, Dean DA, Glazer PM, Chan P et al. Peptide nucleic acid (PNA) binding-mediated induction of human y-globin gene expression. Nucleic Acids Res 1999;27:2806-13.
19. Van der Laan AC, Havenaar P, Oosting RS, Kuyl-Yeheskiely E, Uhlmann E, van Boom JH. Optimization of the binding properties of PNA-(5′)-DNA chimerae. Bioorg Med Chem Lett 1998;17(8):663-8.
20. Nielsen PE. Peptide nucleic acid (PNA): A lead for gene therapeutic drugs. Perspect Drug Discov Des 1996;4:76-84.
21. Eriksson M, Nielsen PE. Solution Structure of a Peptide Nucleic Acid-DNA Duplex. Nature Structur Biol 1996;3:410-3.
22. Nielsen PE, Egholm M, Buchardt O. Evidence for (PNA)2/DNA triplex structure upon binding of PNA to dsDNA by strand displacement. J Mol Recognition 1994;7:165-70.
23. Demidov VV, Yavnilovich MV, Belotserkovskii BP, Frank-Kamenetskii MD, Nielsen PE. Kinetics and mechanism of PNA binding to duplex DNA. Proc Natl Acad Sci USA 1995;92:2637-41.
24. Wittung P, Nielsen PE, Nordén B. Direct observation of PNA strand invasion by circular dichroism. J Am Chem Soc 1996;118: 7049-54.
25. Boffa LC, Carpaneto EM, Allfrey VG. Isolation of active genes containing CAG repeats by DNA strand invasion by a peptide nucleic acid. Proc Natl Acad Sci USA 1995;92:1901-5.
26. Peffer NJ, Hanvey JC, Bisi JE, Thomson SA, Hassman CF, Noble SA et al. Strand-invasion of duplex DNA by peptide nucleic acid oligomers. Proc Natl Acad Sci USA 1993;90:10648-52.
27. Betts L, Josey JA, Veal JM, Jordan SR. A nucleic acid triple helix formed by a peptide nucleic acid-DNA complex. Science 1995;270:1838-41.
28. Nielsen PE. Sequence-specific recognition of double-stranded DNA by peptide nucleic acids. Adv DNA Seq-Spec Agents 1998;3:267-78.
29. Nielsen PE, Egholm M, Berg RH, Buchardt O. Peptide nucleic acids (PNA). Oligonucleotide analogues with a polyamide backbone. In: Crook S, Lebleu B, editors. Antisense research and application, pp. 363-73. Boca Raton: CRC Press.
30. Boffa LC, Morris PL, Carpaneto EM, Louissaint M, Allfrey VG. Invasion of the CAG triplet repeats by a complementary peptide nucleic acid inhibits transcription of the androgen receptor and TATA-binding protein genes and correlates with refolding of an active nucleosome containing a unique AR gene sequence. J Biol Chem 1996;271:13228-33.
31. Boffa LC, Carpaneto EM, Mariani MR, Louissaint M, Allfrey VG. Contrasting effects of PNA invasion of the chimeric DMMYC gene on transcription of its myc and PVT domains. Oncol Res 1997;9:41-51.
32. Gambacorti-Passerini C, Mologni L, Bertazzoli C, Le Coutre P, Marchesi E, Grignani F et al In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid. Blood 1996;88:1411-7.
33. Vickers TA, Griffith MC, Ramasamy K, Risen LM, Freier SM. Inhibition of NF-kB specific transcriptional activation by PNA strand invasion. Nucleic Acids Res 1995;23:3003-8.
34. Uhlmann E, Peyman A, Breipohl G, Will DW. PNA: Synthetic polyamide nucleic acids with unusual binding properties. Angew Chem Int Edit 1998;37:2797-823.
35. Nielsen PE. Peptide nucleic acids (PNA): Potential antiviral agents. Antiviral News 1993;1:37-9.
36. Knudsen H, Nielsen PE. Application of PNA in cancer therapy. Anticancer Drug Des 1997;8:113-8.
37. Mollegaard NE, Buchardt O, Egholm M, Nielsen PE. PNA-DNA Strand displacement loops as artificial transcription promoters. Proc Natl Acad Sci USA 1994;91:3892-5.
38. Lowrey CH, Nienhuis AW. Brief report: treatment with azacytidine of patients with end stage β-thalassemia. N Engl J Med 1993;329:845-8.
39. Dover GJ, Brusilow S, Samid D. Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N Engl J Med 1992;327:569-70.
40. Fibach E, Prasanna P, Rodgers GP, Samid D. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and b-thalassemia. Blood 1993;82:2203-9.
41. Rodgers GP, Rachmilewitz EA. Novel treatment options in the severe b-globin disorder. Br J Haematol 1995;91:263-8.
42. Rochette J, Craig JE, Thein SL. Fetal hemoglobin levels in adults. Blood Reviews 1994;8:213-24.
43. Ley TJ. The pharmacology of hemoglobin switching: of mice and men. Blood 1991;77:1146-52.
44. Bianchi N, Osti F, Rutigliano C, Corradini FG, Borsetti E, Tomassetti M et al. The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells. Br J Haematol 1999;104:258-65.
45. Mischiati C, Borgatti M, Bianchi N, Rutigliano C, Tomassetti M, Feriotto G et al. Interaction of the human NF-kB p52 transcription factor with FNA-PNA hybrids mimicking the NF-kB binding sites of the human immunodeficiency virus type 1 promoter. J Biol Chem 1999;274:33114-22.
46. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nature Med 1997;3:894-9.
47. Lim CS, Jabrane-Ferrat N, Fontes JD, Okamoto H, Garovoy MR, Peterlin BM et al. Sequence-independent inhibition of RNA transcription by DNA dumbbells and other decoys. Nucleic Acids Res 1997;25:575-81.
48. Kawamura I, Morishita R, Tomita N, Lacey E, Aketa M, Tsujimoto S et al. Intratumoral injection of oligonucleotides to the NF kappaB bindings site inhibits cachexia in a mouse tumor model. Gene Ther 1999;6:91-7.
49. Wittung P, Kim SK, Buchardt O, Nielsen PE, Nordén B. Interactions of DNA binding ligands with PNA-DNA hybrids. Nucleic Acids Res 1995;22:5371-7.
50. Mcshean WM, Rossen RD, Laughter AH, Trial J, Kessler DJ, Zendegui JG et al. Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices. J Biol Chem 1992;267:5712-21.
51. Bianchi N, Rutigliano C, Passadore M, Tomassetti M, Pippo L, Mischiati C et al. Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription. Biochem J 1997;326:919-27.
52. Bianchi N, Passadore M, Rutigliano C, Feriotto G, Mischiati C, Gambari R. Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Disruption of nuclear factor DNA complexes and inhibition of in vitro transcription. Biochem Pharmacol 1996;52:1489-98.
53. Nielsen PE, Christensen L. Strand displacement binding of a duplex forming homopurine PNA to a homopyrimidine duplex DNA target. J Am Chem Soc 1996;118:2287-8.
54. Barbieri R, Giacomini P, Volinia S, Nastruzzi C, Mileo AM, Ferrini U et al. Human HLA-DR alpha gene: a rare oligonucleotide (GTATA) identifies an upstream sequence required for nuclear protein binding. FEBS Lett 1990;268:51-4.
55. Feriotto G, Mischiati C, Gambari R. Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNase I foot-printing study. Biochem J 1994;299:451-8.
56. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-89.
57. Demidov V, Potaman VN, Frank-Kamenetskii MD, Buchardt O, Egholm M, Nielsen PE. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem Pharmacol 1994;48:1309-13.
58. Berg OG, von Hippel PH. Selection of DNA binding sites by regulatory proteins. Trends Biochem Sci 1988;13:207-11.
59. Faisst S, Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 1992;20:3-26.
60. Gaynor G. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992;6:347-63.
61. Locker J. Transcription control: cis-elements and trans-factors. In: Hamens BD, Higgins SJ, editors. Oxford: Gene transcription: a practical approach. Oxford: Oxford University Press, 1993: 321-45.
62. Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989;2: 371-8.
63. Wingender E. Compilation of transcription regulatory proteins. Nucleic Acids Res 1988;16:357-69.
64. Lagriffoule P, Wittung P, Eriksson M, Jensen KK, Nordén B, Buchardt O et al. Peptide Nucleic Acids (PNAs) with a conformationally constrained, chiral cyclohexyl derived backbone. Chem Eur J 1997;3:912-9.
65. Haaima G, Lohse A, Buchardt O, Nielsen PE. Peptide Nucleic Acids (PNAs) containing thymine monomers derived from chiral amino acids: hybridization and solubility properties of D-Lysine PNA. Angew Chem Int Edit 1996;35:1939-42.
66. Wittung P, Eriksson M, Lyng R, Nielsen PE, Norden B. Induced chirality in PNA-PNA duplexes. J Am Chem Soc 1995;117: 10167-73.
67. Peyman A, Uhlmann E, Wagner K, Augustin S, Weiser C, Will DW et al. Phosphonic ester nucleic-acids (PHONAS) - oligonucleotide analogs with an achiral phosphonic acid ester backbone. Angew Chem Int Edit 1997;36:2809-12.
68. Misra HS, Pandey PK, Modak MJ, Vinayak R, Pandey VN. Polyamide nucleic acid-DNA chimera lacking the phosphate backbone are novel primers for polymerase reaction catalyzed by DNA polymerases. Biochemistry 1998;37:1917-25.
69. Petersen KH, Jensen DK, Egholm M, Nielsen PE, Buchardt O. Bioorg Med Chem Lett 1995;5:1119-24.
70. Koppitz M, Nielsen PE, Orgel L. Formation of oligonucleotide-PNA-Chimeras by Template-directed Ligation. J Am Chem Soc 1997;120:4563-9.